ACCESSWIRE
23 Nov 2022, 23:55 GMT+10
PURbridge™, an advanced synthetic and new form of bioactive glass, is positioned to significantly increase the Company's revenue throughout 2023
IRVINE, CA / ACCESSWIRE / November 23, 2022 / HippoFi, Inc. (formerly ORHub), (OTC PINK:ORHB), a diversified company focused on the biotech and fintech segments, is proud to announce its newest biologic product, PURbridge™. This new form of active bioglass expands the already extensive portfolio of HippoFi's division of Regenerative Therapeutics, which continues to target a total Spine market, anticipated to reach $18 billion in 2023.
'Successful lumbar and thoracic spine fusion surgeries require biological products to bridge new bone growth between vertebral bodies. PURbridge™ is uniquely positioned to solve this critical patient need and desired surgical outcome. Our proprietary bridge-like structure has been specifically formulated by interweaving bioactive glass and our absorbent Tri-pore NanoCrystals™ with flexible fibers of semi-crystalline molecules of collagen. This unique composition of three highly biocompatible elements results in a flexible and strong ‘bioactive bridge' which holds its shape and position while helping the patient heal, spanning the intended area with solid bone,' explained Ryan Fernan, Head of PUR Biologics.
'Our purpose as an emerging healthcare leader is to provide innovative biotech products and fintech software to generate extraordinary growth in revenue, market presence, and innovation,' stated CJ Wiggins, Founder, Executive Chairman & CEO of HippoFi. 'PURbridge™ is an outstanding clinical solution which immediately expands our product portfolio of advanced synthetics in Spine. We are committed to become the global leader in biological products for growing bone in spine procedures, to lead the future of regenerative therapeutics in regenerating joint cartilage and spinal disc, and to become the first financier and digital payment platform for all surgically implanted products between hospitals, ASC, and medical device vendors.'
HippoFi is traded on the OTC under the symbol 'ORHB'.
About HippoFi, Inc.
HippoFi, Inc. delivers its cutting-edge healthcare innovations through an extensive sales channel network while implementing first-to-market solutions in the multibillion-dollar Biotech, Fintech, and Artificial Intelligence (AI) markets. HippoFi comprises three segments: Regenerative Therapeutics, Digital Payments, and AI, which utilize the same customer channels to commercialize solutions, drive revenue, and improve patient outcomes.
PUR Biologics®, HippoFi's Regenerative Therapeutic division, offers a portfolio of innovative biological products and proprietary technologies for bone growth in surgical Spine procedures as well as patented bioactive cellular matrix compositions and advanced autologous cell therapies for regenerating cartilage in joints and spinal discs.
HippoFi-Pay™, the company's Digital Payment division, operates a surgical implant and business management software, which standardize processes at the point of surgical care with improved logistics and efficiencies to provide medical device and biologic vendors with HIPAA & NPI compliant implant verification and faster payments.
HippoFi's AI division is focused specifically on the use of AI for early diagnosis and predictive modeling of Cancer and improving business decisions specific to Spine surgery.
HippoFi, Inc. is publicly traded under the symbol: ORHB and is headquartered in Irvine, California. For more information, please visit: www.HippoFi.com and www.PURbiologics.com
Contact:
Jason Brown
Shareholder Communications
HippoFi, Inc.
612-209-7565
SOURCE: HippoFi, Inc.
Get a daily dose of San Francisco Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to San Francisco Star.
More InformationThe British Defense Ministry said Saturday that Russia "highly likely" suffered more than 300 casualties in a New Year's Day ...
Washington [US], January 28 (ANI): US President Joe Biden said that he was "outraged and deeply pained" to see the ...
© Provided by Xinhua HEFEI, Jan. 28 (Xinhua) -- A pleasant surprise has magical power. From cosmetics and toys to ...
American taxpayers are footing the bill for the conflict while domestic issues are being neglected, a group of Republicans in ...
Scoring two goals hardly qualifies as an offensive explosion, but it was more than enough to provide the New York ...
washington - A summary of Uyghur-related news around the worldA Kazakh woman in Xinjiang asks journalists to publicize her case ...
WASHINGTON, D.C.: Finland and Sweden are prepared to join the NATO alliance, the U.S. State Department announced this week.The move ...
WASHINGTON D.C.: The US Justice Department has filed an antitrust complaint claiming that Google is abusing its dominance in digital ...
Public health experts have welcomed Mexico's ban on cigarette smoking in all public places, including hotels and beaches, after the ...
YONKERS, New York: After testing discovered harmful levels of heavy metals in chocolate, consumer magazine Consumer Reports has urged four ...
OUAGADOUGOU, Burkina Faso: As Burkina Faso, in western Africa, faces an Islamist insurgency, it is set to end a military ...
TOKYO, Japan: Japanese Prime minister Fumio Kishida said this week that it was "now or never" for Japan, one of ...